Schizophrenia is a brain disorder marked by changes in thought, perception and behaviour. It is also associated with poorer physical health, including low bone density and a higher risk of fractures. Long-term antipsychotic use, reduced physical activity, smoking and vitamin D deficiency are known contributors. A recent genetic study has now explored whether the link between schizophrenia and fragile bones may also involve shared biological pathways.
Genetic Study on Shared Risk
Researchers analysed DNA data from more than half a million people across international studies on schizophrenia and osteoporosis. The aim was to test whether the two conditions share genetic influences. Instead of looking only at broad genome-wide patterns, the study examined DNA regions one by one. This approach helped detect smaller and more specific overlaps that earlier methods may have missed.
Heel Bone Shows Strongest Overlap
The strongest shared genetic signal appeared in heel bone strength. Other skeletal sites showed much weaker links, and the forearm showed no clear overlap. This suggests that any shared genetic influence is not uniform across the skeleton. It may reflect either the greater number of studies on heel bone density or a real biological connection involving weight-bearing bones and metabolic pathways.
Clinical Significance for Psychiatric Care
The findings do not change immediate treatment for schizophrenia, but they show an important care gap. Bone health is often not routinely monitored in psychiatric practice. Clinicians usually focus on short-term medication effects, such as sedation or falls, rather than long-term fracture risk. The study supports a more holistic approach to mental health care, with greater attention to physical risks such as osteoporosis and bone fragility.
Last Modified: April 27, 2026